Yexiong Tan
Second Military Medical University(CN)Shanghai Cancer Institute(CN)Eastern Hepatobiliary Surgery Hospital(CN)
Publications by Year
Research Areas
Cholangiocarcinoma and Gallbladder Cancer Studies, Hedgehog Signaling Pathway Studies, Metabolomics and Mass Spectrometry Studies, Pediatric Hepatobiliary Diseases and Treatments, Cancer, Lipids, and Metabolism
Most-Cited Works
- → Metabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue Metabolomics(2013)410 cited
- → Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study(2012)391 cited
- → A Large‐scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma(2017)369 cited
- → Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats(2012)283 cited
- → ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1α(2016)250 cited
- → MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma(2012)211 cited